Bahandianon, Feleciano D.

HRN: 15-12-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/13/2023
02/20/2023
PO
100,000IU
BID
Oral Thrush
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: